PBS updates

Retrovir (Zidovudine)

zidovudine 250 mg capsule, 40 · ORAL · PBS code 10360G

STREAMLINED

What it costs

AU$129.81 PBS-determined price per 240 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2015-07-01.
  • • Repeats: 5.
  • • PBS program: CA.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

HIV infection


Initial


Patient must be antiretroviral treatment naive; AND

The treatment must be in combination with other antiretroviral agents.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

HIV infection


Continuing


Patient must have previously received PBS-subsidised therapy for HIV infection; AND

The treatment must be in combination with other antiretroviral agents.

Sponsor: ViiV Healthcare Pty Ltd ABN 46 138 687 448

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.